Skip to main content
Group of diverse business people having a meeting in a modern work space

Corporate Partnership Programme

About the Corporate Partnership Programme

The IAS Corporate Partnership Programme (CPP) provides industry partners with an exclusive gateway to collaborate with top scientists, policy makers, community representatives, other industry partners and stakeholders to drive innovation across the HIV prevention and care continuum.

Why join the CPP?

Accelerate innovation from concept to market:

Join forces with the leading minds in the field of HIV to shape agendas, influence discussions and move innovations faster into real-world applications. Our partners have exclusive access to the latest insights from the global HIV community.

Access exclusive networks and shape the conversation:

Enjoy year-round engagement with leading scientists, policy makers, civil society, academics, industry and other key stakeholders in the global HIV response. In addition to joining thematic roundtables and quarterly strategy calls, you will also have the chance to co-author position papers. You will have exclusive access to, and speaking opportunities at CPP-convened events, including expert panels, workshops, roundtables and meet-and-greets with IAS leadership.

Amplify your impact:

Recognition on IAS online platforms, in publications and at major international HIV conferences. This unique opportunity to demonstrate your commitment and contribution to social responsibility and leadership in improving public health outcomes.

Engage through our initiatives

The Industry Liaison Forum convenes and catalyses multi-stakeholder dialogue between industry and non-industry actors on a broad range of topics relevant for pharmaceutical, diagnostic and other industry sectors involved in the HIV response.

Find out more

alternative text

The Towards an HIV Cure: Industry Collaboration Group focuses and identifies avenues for biomedical industry and non-industry collaboration in HIV cure research and development (R&D).

Find out more

alternative text

The HIV Vaccine Industry Partnership Group encourages and facilitates the contribution of the biomedical industry and non-industry to address the complexities of HIV vaccine R&D.

Find out more

alternative text

Join the Corporate Partnership Programme now!

With three flexible membership tiers – Bronze, Silver and Gold – you can choose the level of engagement that best aligns with your preferred level of involvement. Each tier is designed to maximize your impact and engagement in the global HIV community; this includes access to industry groups, complimentary registrations for IAS-convened conferences and exclusive invites to networking events.

Join the Corporate Partnership Programme today!

Simply contact us at cpp@iasociety.org. Our team will provide all the information you need and guide you through the process.

Join now

Corporate Partnership Programme partners

The IAS would like to thank its 2025 Corporate Partners:
 

Partner logos

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.